Skip to content
Toggle navigation
ABOUT US
MANAGEMENT TEAM
BOARD OF DIRECTORS
DyrctAxess
PRESTALIADIRECT
PRODUCTS
PRESTALIA
PARTNERING
INVESTOR RELATIONS
PRESS RELEASES
EVENTS & PRESENTATIONS
ANNUAL MEETINGS
SEC FILINGS
INVESTOR RESOURCES
CORPORATE GOVERNANCE
FAQs
CONTACT
1/25/2012
Marina Biotech Starts Cohort 2 of its Phase 1b START-FAP Clinical Trial of CEQ508
Post navigation
←
2/1/2012
1/19/2012
→
Scroll Up